Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 October 2005, Vol. 106, No. 8, pp. 2655-2662.
Prepublished online as a Blood First Edition Paper on June 30, 2005; DOI 10.1182/blood-2005-01-0028.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-01-0028v1
106/8/2655    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, B.
Right arrow Articles by Strayer, D. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, B.
Right arrow Articles by Strayer, D. S
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted January 5, 2005
Accepted February 23, 2005

In vivo gene transfer into rat bone marrow progenitor cells using rSV40 viral vectors

Bianling Liu, Judy Daviau, Carmen N Nichols, and David S Strayer*

Department of Pathology, Jefferson Medical College, Philadelphia, PA, USA
Division of Animal Resources, Thomas Jefferson University, Philadelphia, PA, USA

* Corresponding author; email: david.strayer{at}jefferson.edu.

Hematopoietic stem cell (HSC) gene transfer has been attempted almost entirely ex vivo, and has been limited by cytokine-induced loss of self-renewal capacity and transplantation-related defects in homing and engraftment. Here, we attempted to circumvent such limitations by injecting vectors directly into the bone marrow (BM), to transduce HSC in their native environment. SV40-derived gene delivery vectors were used because they transduce resting CD34+ cells very efficiently. Rats received SV(Nef-FLAG), carrying FLAG marker epitope, or a control rSV40, directly into both femoral marrow cavities. Intracellular transgene expression by PB or BM cells was detected by cytofluorimetry. An average of 5.3% of PB leukocytes expressed FLAG for the entire study, 56 weeks. Transgene expression was sustained in multiple cell lineages, including granulocytes (average, 3.3% of leukocytes, 20.4% of granulocytes), CD3+ T lymphocytes (average, 0.53% of leukocytes, 1% of total T cells) and CD45R+ B lymphocytes, indicating gene transfer to long-lived progenitor cells with multilineage capacity. An average of 15% of femoral marrow cells expressed FLAG up to 16.5 months post-transduction. Thus, direct intramarrow administration of rSV40s yields efficient gene transfer to rat BM progenitor cells, and may be worthy of further investigation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020